#1
#1 out of 1
health12h ago
Glucotrack publishes peer-reviewed study showing 240-day CBGM accuracy (MARD 6.8%)
- Glucotrack reports peer‑reviewed data showing CBGM accuracy over 240 days in sheep.
- The study involved 34 devices tested in 17 sheep, with 79 IVGTTs analyzed.
- No device‑related safety events were observed during the 240‑day study period.
- Results bolster progression toward FDA IDE submission and further development.
- The summary notes the Journal of Diabetes Research article as the data source.
- The findings support continued clinical development for Glucotrack devices.
- The data come from an in‑vivo ovine study extending up to 240 days.
- The summary emphasizes the MARD metric as a key accuracy indicator.
- The announcement ties the study to potential regulatory considerations with the FDA.
- The source article is cited as the basis for the report’s claims.
Vote 0